The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Rayner Intraocular Lenses sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Rayner Intraocular Lenses Ltd (Rayner), a subsidiary of Rayner Surgical Group Ltd, is a medical device company that offers intraocular lenses (IOL) and proprietary injection devices used in cataract surgery. The company offers IOL products such as aspheric Mono focal, aspheric Toric, multifocal and others. It provides supplementary IOL products including multifocal, spheric, Toric and multifocal Toric. Rayner also offers injectors and ophthalmic viscoelastic devices, Ocular Surface Disease (OSD) solutions. The company offers injection systems to complement its single-use soft-tipped injectors. It offers various pharmaceutical and eye care products which are used in treating dry eye, inflammation, allergy and corneal oedema. Rayner also collects Patient Reported Outcomes (PROs) and supports surgeons in selecting and ordering IOLs through its digital health platform RayPRO. The company has operations in Germany, Canada, Russia, India, Ireland, Poland, New Zealand, the US, Italy, Spain, Portugal and the UK. Rayner is headquartered in Worthing, West Sussex, the UK Key subsidiaries of Rayner Intraocular Lenses include Rayner, Rayner SP ZO O, Rayner Surgical Ireland, Surgicon Healthcare and Rayner Surgical.
The key metrics of Rayner Intraocular Lenses related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Rayner Intraocular Lenses is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Rayner Intraocular Lenses.
For a detailed understanding of the performance of Rayner Intraocular Lenses, buy the report here.